InnovationRx is your weekly digest of healthcare information. To get it in your inbox, subscribe right here.
AFP by way of Getty Photos
Melinda French Gates based Pivotal Ventures to broaden girls’s energy and affect utilizing quite a lot of levers, together with philanthropy, advocacy and investments. In line with PitchBook, enterprise capital for ladies cofounded firms hit an all-time excessive of 20% in 2023, although women-only based startups had been solely 2%. . “We predict if we’re placing extra capital within the fingers of girls, they’ll unlock options to among the greatest issues which can be dealing with our society right now,” Pivotal Ventures managing director Erin Harkless Moore informed Forbes.
Harkless Moore has zeroed in on the “Care Economic system,” which Pivotal Ventures estimates is round $648 billion and broadly contains any obligations associated to caregiving, starting from girls caring for their very own well being to the well-being of their youngsters and growing old members of the family. Harkless Moore is making direct investments in firms and likewise investing in women-led enterprise capital funds which can be working to “scale back burdens of care, decrease prices of care and enhance entry to care.”
Caregiving can be a problem that has bipartisan assist – two out of three individuals surveyed mentioned the federal government “must do extra” to handle the challenges and monetary prices of caregiving. Pivotal Ventures has invested in firms together with Tia, which gives in-person and digital girls’s healthcare companies; Mon Ami, which gives a software program resolution to growing old and incapacity companies suppliers; and Summer time Well being, which provides 24/7 message-based entry to pediatricians, amongst others. Among the fund investments embody Amplify Ventures and Outline Ventures.
How Ozempic, Wegovy, Mounjaro, Zepbound Might Assist Deal with Different Ailments
dpa/image alliance by way of Getty Photos
GLP-1 medicine, the category that features standard drugs like Ozempic, Wegovy, and Rybelsus in addition to Mounjaro and Zepbound has not solely confirmed efficient in treating weight reduction and diabetes: Mounting proof suggests these medicine could also be efficient at treating different situations like most cancers, Alzheimer’s and COVID-19.
Learn extra right here.
Pipeline & Deal Updates
Xenotransplants: Biotech firm eGenesis, which is creating genetically modified pig organs for transplant into people, closed a $191 million series D round. (Learn extra about eGenesis in our function story from earlier this 12 months.)
Cell Remedy: ArsenalBio, which is creating CAR-T cell therapies for most cancers, closed a $325 million series C financing round.
House Well being: Vesta Healthcare, which gives digital home-based care, has raised $65 million in fairness and debt financing led by RA Capital Administration. The corporate says it’s serving greater than 50,000 sufferers and has developed software program that connects the sufferers, household, house care businesses and insurance policy.
Radiopharma: Novartis has begun construction on two completely different manufacturing amenities within the U.S. for radioligand therapies to deal with most cancers. One is in Carlsbad California and one is in Indianapolis.
HealthTech: PatientPartner, a affected person engagement startup based by Forbes 30 Underneath 30 alums George Kramb and Patrick Frank, raised a $7 million seed round.
Weight problems: Haya Therapeutics, which is creating genomic remedies for metabolic illnesses, announced a research agreement with Lilly to develop medicine for weight problems and associated situations. The combination deal is probably price as much as $1 billion in milestone funds, plus royalties on any medicine authorized.
Tencent-Backed AI Drug Researcher Xtalpi’s Shares Double On Income Rise
Shanshan Kao/Forbes Asia
Xtalpi, a Shenzhen, China-based AI drug discovery firm, noticed its shares soar 108% on the Hong Kong inventory change over the previous week, boosting its market cap to $5.5 billion. The transfer comes on the again of Xtalpi’s gross sales progress, which it attributed to extra prospects utilizing its AI-powered drug discovery companies, together with Pfizer and Johnson & Johnson. The corporate additionally scored a five-year $135 million take care of Chinese language billionaire Zhu Gongshan’s power firm GCL Group to collectively analysis and develop new supplies in areas akin to lithium-ion batteries.
Learn extra right here.
Different Healthcare Information
Ceremony Assist Picks Insider CEO As Firm Emerges From Chapter
FDA Approves Up to date Novavax COVID Vaccine Week After Approving Moderna And Pfizer’s Pictures
Highmark Blue Cross Reaps $417 Million Revenue As Well being Plans And Suppliers Develop
Moderna’s First mRNA Mpox Vaccine Beats Licensed Rival Pictures In Early Testing
Throughout Forbes
What Else We’re Studying
How race became ubiquitous in medical decision-making tools (STAT)
Feds Killed Plan To Curb Medicare Advantage Overbilling After Industry Opposition (KFF Health News)
The biology of smell is a mystery — AI is helping to solve it (Nature)
